奥鲁替尼REZLIDHIA（olutasidenib）

奥鲁替尼REZLIDHIA（olutasidenib）：IDH1抑制剂 急性髓细胞样白血病; 肠易激综合征; 腹泻; 软骨肉瘤; 骨髓增生异常综合征。目前FDA已经批准上市。

我公司开发各类医药中间体，尤其擅长手型拆分类中间体，我公司研发实力：三个博士，一个博士导师，30多名研究生本开人员，我们真诚希望和国内外各大药厂深度合作，在新药或首仿的前期工作，标准品，技术资料，后期原料供应。我们公司成立23年，一直把服务放在位，和国内很多药厂都有深度合作。

               诚挚以待，共创未来!!!!

          www.cdyygk.com

     联系人：叶经理   13308012069  

     邮件：13308012069@189.cn

Our company,Chengdu YuYang, develops all kinds of medical intermediates, especially good at hand type disclassification intermediates, our research and development strength: three doctors, a doctoral supervisor, more than 30 graduate students this open staff, we sincerely hope to cooperate with major pharmaceutical factories at home and abroad, in the early work of new drugs or first imitation, standard products, technical data, late material supply. Our company was founded 23 years ago, always put service in the first place, and many domestic and oversea pharmaceutical manufacturers have deep cooperation.

Sincerely look forward to creating a better future!!!!

Contact: Helen Liu +0086-13852538605

Email: 985905985@qq.com

Website : www.cdyygk.com